These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18421085)

  • 1. Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization.
    She H; Nakazawa T; Matsubara A; Connolly E; Hisatomi T; Noda K; Kim I; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5008-14. PubMed ID: 18421085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization.
    She H; Nakazawa T; Matsubara A; Hisatomi T; Young TA; Michaud N; Connolly E; Hafezi-Moghadam A; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2268-77. PubMed ID: 17460290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy induces caspase-dependent apoptosis in rat CNV model.
    Matsubara A; Nakazawa T; Noda K; She H; Connolly E; Young TA; Ogura Y; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4741-7. PubMed ID: 17898299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
    Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
    Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine protects against chorioretinal damage induced by photodynamic therapy for experimental choroidal neovascularization in a rat model.
    Kim TW; Moon JW; Yu HG
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():12-17. PubMed ID: 29679669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.
    Zacks DN; Ezra E; Terada Y; Michaud N; Connolly E; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
    Husain D; Kramer M; Kenny AG; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VII-verteporfin for targeted photodynamic therapy in a rat model of choroidal neovascularization.
    Lu F; Hu Z; Sinard J; Garen A; Adelman RA
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3890-6. PubMed ID: 19357351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone.
    Augustin AJ; Puls S; Offermann I
    Retina; 2007 Feb; 27(2):133-40. PubMed ID: 17290193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy of experimental choroidal neovascularization in the mouse.
    Odergren A; Ming Y; Kvanta A
    Curr Eye Res; 2006 Sep; 31(9):765-74. PubMed ID: 16966149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Photodynamic therapy with visudine in combination with intravitreal kenalog in the treatment of choroidal neovascularization].
    Neroev VV; Riabina MV; Chikovani KR; Neroeva NV
    Vestn Oftalmol; 2009; 125(1):55-7. PubMed ID: 19284105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
    Husain D; Kim I; Gauthier D; Lane AM; Tsilimbaris MK; Ezra E; Connolly EJ; Michaud N; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
    Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of targeted PDT and anti-VEGF therapy for rat CNV by RGD-modified liposomal photocyanine and sorafenib.
    Wang JL; Xi Y; Liu YL; Wang ZH; Zhang Q
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):7983-9. PubMed ID: 24204046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
    Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
    Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV.
    Lange N; Ballini JP; Wagnieres G; van den Bergh H
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):38-46. PubMed ID: 11133846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy with verteporfin in paediatric and young adult patients: long-term treatment results of choroidal neovascularisations.
    Lipski A; Bornfeld N; Jurklies B
    Br J Ophthalmol; 2008 May; 92(5):655-60. PubMed ID: 18356263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Laser-Induced Choroidal Neovascularization by Hematoporphyrin Dimethylether-Mediated Photodynamic Therapy in Rats.
    Yan YJ; Bao LL; Zhang LJ; Bian J; Hu TS; Zheng MZ; Chen DY; Yu XH; Chen ZL
    Biol Pharm Bull; 2017; 40(12):2088-2095. PubMed ID: 29199233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.